MERS-CoV an emerging viral zoonotic disease: Three years after and counting

Recent Patents on Anti-Infective Drug Discovery

Volumn 9, Issue 3, 2015, Pages 159-160

  Memish, Ziad A ^a  

^a ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; RIBAVIRIN;

AFRICA; BAT; DISEASE TRANSMISSION; EDITORIAL; GERIATRIC PATIENT; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESPIRATORY DISTRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAUDI ARABIA; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS INFECTION; WORLD HEALTH ORGANIZATION;

EID: 84930518827     PISSN: 1574891X     EISSN: 22124071     Source Type: Journal    
DOI: 10.2174/1574891X10666150408155131     Document Type: Editorial

References (13)

1. World Health Organization. Global alert and response (GAR). Situation reports with epidemiological data: Archive. Available at: http://www.who.int/csr/disease/ebola/situation-reports/archive/en/. (Accessed on: July 14, 2015).
2. World Health Organization. WHO risk assessment: Human infection with avian influenza A (H7N9) virus as of 2 October 2014. Available at: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/riskassessment_h7n9_2Oct14.pdf?ua=1. (Accessed on: July 15, 2014).
3. World Health Organization. Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERSCoV) - Oman. Disease outbreak news as of 23 January 2015. Available at: http://www.who.int/csr/don/23-january-2015-mers-oman/en/. (Accessed on: January 10, 2015).
4. World Health Organization. Available at: http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/asof. (Accessed on: July 14, 2014).
5. Al-Gethamy M, Corman VM, Hussain R, Al-Tawfiq JA, Drosten C, Memish ZA. A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker. Clin Infect Dis 2015; 60(6): 973-4.
6. KSA MoH MERS-CoV infection prevention and control. Avaialble at: http://www.moh.gov.sa/en/CCC/Regulations/Final-MERSCoV%20IPC%20Guidelines-24.06.2014.pdf. (Accessed on: July 14, 2014).
7. Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus: Epidemiology and disease control measures. Infect Drug Resist 2014; 7: 281-7.
8. Memish ZA, Al-Tawfiq JA. Middle East respiratory syndrome coronavirus infection control: The missing piece? Am J Infect Control 2014; 42(12): 1258-60.
9. Who Mers-Cov Research Group. State of knowledge and data gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in humans. PLoS Curr 2013; 5.
10. Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 2013; 19(11): 1819-23.
11. Corman VM, Müller MA, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012; 17(49): 20334.
12. Drosten C, Meyer B, Müller MA, Corman VM, Al-Masri M, Hossain R, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med 2014; 371(9): 828-35.
13. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study. Lancet Infect Dis 2014; 14(11): 1090-5.